Elena Curto Sanchez
@santpau.cat
Scopus Publications
- What Patients With Asthma Share When No One Listens: Multimethod Observational Study of Patient Narratives on Reddit
Elena Curto-Sánchez, Gabriela Salazar-Palacios, Ana Martín-Varillas, Estela Cristina Prieto-Maíllo, Jacinto Ramos-González, Ignacio Dávila-González, Domingo Palacios-Ceña, Juan Nicolas Cuenca-Zaldivar
Journal of Medical Internet Research, 2026
Background The use of social media platforms, such as Reddit, to seek and share information about disease management and treatment strategies is increasingly common. In the context of asthma—a chronic condition characterized by limiting symptoms and exacerbations that require active patient engagement and adherence to treatment—there is a lack of research describing the content of Reddit posts and the specific topics of interest to patients. Objective This study aimed to describe the topics discussed by users on the Reddit asthma forum and identify the sentiments and polarity of the language used in the posts. Methods A retrospective observational study of public posts on the asthma subreddit forum (r/Asthma) over a 1-year period (October 2023-October 2024). All posts and related threads were included, subdivided into hot, news, and top, and those voted “up” or “down,” those that received “awards,” categorized as “golds.” The messages were reviewed manually and excluded if they were not related to asthma. A mixed methods analysis was conducted, comprising (1) analysis using text lemmatization, (2) structural topic modeling to identify topics based on word frequency, and (3) sentiment and polarity analysis. This approach aimed to identify the most frequently used topics on Reddit, detect positive and negative sentiments based on the words used, and acceptance or rejection (polarity) based on the language used in the asthma subreddit. Statistical analyses were performed using R software (version 4.1.3; R Foundation for Statistical Computing), with a significance threshold set at P<.05. Results After removing duplicates, 7806 posts were identified. The suitability of the chosen analysis model was confirmed, as it presented the best balance between exclusivity and semantic coherence. Clusters of 25 topics were identified and distributed according to their weight. The topics with the highest weight were Topic 7 (Symptoms and severity of asthma attacks) and Topic 18 (Causes of asthma). No significant differences were found in the evolution of emerging topics throughout the year except in Topic 20 (Seeking advice from people with asthma; P=.04), Topic 21 (Medical tests that should be reviewed periodically; P=.04), and Topic 22 (Times of year when attacks occur; P=.03). The proportion of feelings and emotions showed a stable trend throughout the year. Discrepancies in feelings and emotions were identified depending on the dictionaries used. Thus, a higher probability of positive feelings was confirmed in the AFINN lexicon. Meanwhile, negative feelings were significant in the Stanford Natural Language Processing, Bing, and National Research Council Canada lexicons. Conclusions These results can serve as a guide to identify hidden patient needs and help professionals develop specific interventions on topics relevant to patients. - Identification of Dual Super-Response in Patients With Asthma and CRSwNP Treated With Mepolizumab
Miguel Estravís, David Carreiras-Quintas, Juan Triviño, Jacqueline Pérez-Pazos, María Gil-Melcón, Asunción García-Sánchez, Jacinto Ramos, Manuel Gómez-García, Emma Moreno-Jimenez, Natalia Morgado, Cristina Martín-García, Francisco Muñoz-Bellido, Elena Curto, Catalina Sanz, María Isidoro-García, Ignacio Dávila
Journal of Investigational Allergology and Clinical Immunology, 2026
Background: Asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) are both type 2 (T2) inflammatory diseases that frequently co-occur and are interconnected through shared immunological pathways. The anti–IL-5 monoclonal antibody mepolizumab has shown efficacy in reducing eosinophilic inflammation and improving clinical outcomes. However, the molecular mechanisms underlying response to treatment, particularly at the transcriptomic level, remain underexplored. We aimed to investigate peripheral blood transcriptomic changes and identify potential biomarkers associated with dual super-response to mepolizumab in patients with severe asthma and CRSwNP. Methods: The study population comprised 29 participants (19 patients with severe asthma and CRSwNP and 10 healthy controls). Whole blood RNA sequencing was performed before and after treatment with mepolizumab in 6 patients, followed by validation of candidate genes using qPCR. Clinical responses were assessed using the FEOS score (FEV1, exacerbations, oral corticosteroids, symptoms) and lung function measurements, and the 22-item Sino-Nasal Outcome Test (SNOT-22) score. Results: Mepolizumab significantly improved clinical parameters, including exacerbation rates, asthma control, and the SNOT-22 score. Transcriptomic analysis identified 156 differentially expressed genes after treatment with mepolizumab, significantly enriching immune and inflammatory pathways. Twelve candidate genes were studied. Three of these genes (PNPLA1, C3AR1, and RGS1) were validated as potential predictors of super-response to treatment of asthma and CRSwNP. Baseline expression levels of RGS1 were associated with dual super-response in asthma and CRSwNP. Conclusion: This study provides new insights into transcriptomic changes following mepolizumab treatment and highlights RGS1 as a potential biomarker for predicting dual super-response in asthma and CRSwNP. Our findings contribute to precision medicine approaches and support the identification of optimal candidates for anti–IL-5 therapy. - FEV1Q as a Predictive Metric for Asthma Outcomes
Diana Betancor, Jose Maria Olaguibel, Victoria del Pozo, Maria Jose Alvarez Puebla, Ebymar Arismendi, Blanca Barroso, Irina Bobolea, Blanca Cárdaba, José Antonio Cañas, Javier Domínguez-Ortega, María-Jesús Cruz, Elena Curto, Alberto Garcia de la Fuente, Francisco Jose González-Barcala, Juan-Alberto Luna-Porta, Cesar Martínez-Rivera, Joaquim Mullol, Xavier Muñoz, César Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto-Retes, Marcela Valverde-Monge, Ignacio Mahíllo-Fernández, Joaquin Sastre
Archivos De Bronconeumologia, 2025 - Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project
MJ Rial, D Betancor, JA Cañas, JM Olaguibel, JM Rodrigo-Muñoz, MJ Alvarez-Puebla, E Arismendi, B Barroso, I Bobolea, B Cárdaba, MJ Cruz, E Curto, V Del Pozo, J Domínguez-Ortega, A Garcia de la Fuente, FJ González-Barcala, JA Luna-Porta, C Martínez-Rivera, J Mullol, X Muñoz, C Picado, V Plaza, S Quirce, L Soto-Retes, M Valverde-Monge, J Sastre
Journal of Investigational Allergology and Clinical Immunology, 2025 - Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma
Lorena Soto-Retes, Javier Milagro, Astrid Crespo-Lessmann, Elena Curto, Éder F. Mateus Medina, Raquel Bailón, Eduardo Gil, Pablo Laguna, Vicente Plaza
Annals of Allergy Asthma and Immunology, 2024 - The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria
Diana Betancor, Blanca Barroso, Marcela Valverde-Monge, Alicia Gomez-Lopez, Joaquin Sastre, José María Olaguibel, José Manuel Rodrigo-Muñoz, Maria Jose Alvarez Puebla, Ebymar Arismendi, Irina Bobolea, Blanca Cárdaba, María Jesús Cruz, Elena Curto, Victoria Del Pozo, Javier Domínguez-Orteg, Francisco-Javier González-Barcala, J.A. Luna-Porta, Carlos Martínez-Rivera, Joaquim Mullol, Xavier Muñoz, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto-Retes, Antonio Valero
Respiratory Medicine, 2024 - Asthma
Celia Pinedo Sierra, Elena Curto Sánchez, Rocio Diaz Campos, Tamara Hermida Valverde, Silvia Sánchez-Cuellar, Ana Fernández Tena
Open Respiratory Archives, 2024
El asma es una enfermedad inflamatoria crónica que afecta alrededor del 5% de la población mundial y genera unos elevados costes sociosanitarios. Para un manejo adecuado de la enfermedad es necesario un correcto diagnóstico, basado en medidas objetivas de la afectación funcional, así como el control de los síntomas y la valoración del riesgo futuro de exacerbaciones. Se ha estimado que un 18% de los pacientes asmáticos en Europa occidental tienen asma grave y aproximadamente el 50% de ellos cuentan con un mal control. La gravedad del asma se establece en función de las necesidades mínimas de tratamiento de mantenimiento para alcanzar el control. Las guías de práctica clínica de asma recomiendan clasificar a los pacientes graves en asma alérgica (T2); asma eosinofílica (T2) y asma no T2 con el fin de establecer el tratamiento más adecuado. En las últimas décadas se han desarrollado nuevas terapias biológicas que pueden aplicarse según el fenotipo y el endotipo del asma, lo que permite hacer un tratamiento selectivo y personalizado. Estos fenotipos y endotipos pueden modificarse a lo largo del tiempo y por ello, la identificación de biomarcadores capaces de predecir la gravedad, el curso de la enfermedad y la respuesta a un determinado tratamiento parece imprescindible. En el asma se han estudiado una gran cantidad de biomarcadores, pero hasta ahora solo algunos pueden usarse fácilmente en la práctica clínica habitual. La aplicación de las tecnologías ómicas (epigenómica, genómica, transcriptómica, proteómica, metabolómica, lipidómica, etc.) que sirvan para este fin, todavía se encuentran en fase de investigación. Asthma is a chronic inflammatory disease that affects about 5% of the world's population and generates high health and social costs. Proper management of the disease requires a correct diagnosis, based on objective measures of functional impairment, as well as symptom control and assessment of the future risk of exacerbations. It has been estimated that 18% of asthma patients in Western Europe have severe asthma and approximately 50% of them have poor control. The severity of asthma is established based on the minimum maintenance treatment needs to achieve control. Asthma clinical practice guidelines recommend classifying severe patients into allergic asthma (T2); eosinophilic asthma (T2) and non-T2 asthma in order to establish the most appropriate treatment. In recent decades, new biological therapies have been developed that can be applied according to the phenotype and endotype of asthma, allowing for selective and personalized treatment. These phenotypes and endotypes can change over time and therefore, the identification of biomarkers capable of predicting the severity, the course of the disease and the response to a given treatment seems essential. A large number of biomarkers have been studied in asthma, but so far only a few can be readily used in routine clinical practice. The application of omics technologies (epigenomics, genomics, transcriptomics, proteomics, metabolomics, lipidomics, etc.) for this purpose is still in the research phase. - Clinical and functional characteristics, possible causes, and impact of chronic cough in patients with cerebellar ataxia, neuropathy, and bilateral vestibular areflexia syndrome (CANVAS)
Esther Palones, Elena Curto, Vicente Plaza, Lidia Gonzalez-Quereda, Alba Segarra-Casas, Luis Querol, Federico Bertoletti, María José Rodriguez, Pía Gallano, Astrid Crespo-Lessmann
Journal of Neurology, 2024
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is an hereditary autosomal recessive disease. Recent studies propose including chronic cough (CC) as a symptom of CANVAS. For 10 patients with CANVAS as genetically confirmed by biallelic expansion of the AAGG repeat motif (AAGGGexp) in intron 2 of replication factor C subunit 1 (RFC1), our aim was, as a multidisciplinary team, to describe clinical and functional characteristics and possible causes of CC following European Respiratory Society (ERS) recommendations, and to evaluate CC impact on quality of life (QoL) using self-administered questionnaires (Cough Severity Diary, Leicester Cough Questionnaire, Discrete Emotions Questionnaire, and EQ-5D-5L). In all 10 patients, the CC was a dry cough that developed several years prior to the neurological symptoms (mean 14.2 years); 7 patients had symptoms compatible with gastroesophageal reflux (GER), 5 with pathological GER diagnosed by 24-h esophageal pH testing, and 6 patients had impaired esophageal motility diagnosed by high-resolution esophageal manometry, most frequently ineffective peristalsis. Although further studies are required for confirmation, we conclude that CC may be a characteristic prodrome of CANVAS and may be related to GER and esophageal disorders. Furthermore, CC affects patients’ QoL, especially in the psychosocial sphere. - Erratum to “Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia” [Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011)]
Esther Palones, Elena Curto, Anna Pelegrí, Marina Arilla, Ingrid Solanes, Astrid Crespo-Lessmann
Archivos De Bronconeumologia, 2024 - Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort
D Betancor, M Otal, JM Olaguibel, JM Rodrigo-Muñoz, MJ Alvarez Puebla, E Arismendi, P Barranco, B Barroso, I Bobolea, B Cárdaba, MJ Cruz, E Curto, V Del Pozo, J Domínguez-Ortega, FJ González-Barcala, JA Luna-Porta, C Martínez-Rivera, J Mullol, X Muñoz, C Picado, V Plaza, S Quirce, MJ Rial, I Roibás-Veiga, L Soto-Retes, A Valero, M Valverde-Monge, J Sastre
Journal of Investigational Allergology and Clinical Immunology, 2024
Methods:Asthma was diagnosed based on the GEMA guidelines and included a postBD FEV1>12% and 200ml on spirometry and/or methacholine PC20<16 mg/ml.Study data included demographic and clinical characteristics, asthma treatment, asthma severity (following GINA guidelines) [1] and control (assessed using the Asthma Control Test (ACT)) and the number and severity of exacerbations.Lung function tests (spirometry, methacholine, and plethysmography), sputum analysis, peripheral blood eosinophilia (PBE) and fractional exhaled nitric oxide (FeNO) were also collected.A full description of the MEGA cohort has been published previously [13].The ethics committees of each participating hospital approved this study.All subjects provided signed informed consent.Quantitative variables were described as mean and standard deviation, and qualitative variables by absolute and relative frequencies.Inter-group comparisons were performed using the chi-square test or Fisher's exact test for qualitative variables and the ANOVA or Kruskal-Wallis test for quantitative variables.The agreement percentage was used to calculate the agreement between both diagnosis criteria.Statistical analysis was carried out using GraphPadInstat6 (GraphPadSoftware Inc, San Diego, CA).P-values <0.05 were considered significant. Limitations:A large proportion of patients from the MEGA cohort, 57.4%, have not undergone post-bronchodilation spirometry, or there is no clinical data about them.As a result, they were excluded from the study.As the methacholine challenge was an inclusion criterion, postBD spirometry was not performed in all patients.Moreover, adequate sputum was obtained from a small sample of patients, just 12.5% from the ACO group and 32.8% from non-ACO.Therefore, the sputum inflammatory profile results could not represent all the studied patients. - Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers
Christian Romero-Mesones, Maria-Jesus Cruz, Isam Alobid, Blanca Barroso, Ebymar Arismendi, Pilar Barranco, Diana Betancor, Irina Bobolea, Blanca Cárdaba, Elena Curto, Gemma Domenech, Javier Domínguez-Ortega, David Espejo, Francisco-Javier González-Barcala, Juan-Alberto Luna-Porta, Carlos Martínez-Rivera, Paula Méndez-Brea, Joaquim Mullol, José-María Olaguibel, Cesar Picado, Vicente Plaza, Victoria del Pozo, Santiago Quirce, Manuel-Jorge Rial, José-María Rodrigo-Muñoz, Joaquin Sastre, Sandra Serrano, Lorena Soto-Retes, Antonio Valero, Marcela Valverde-Monge, Xavier Munoz
Journal of Allergy and Clinical Immunology in Practice, 2023 - The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort
Diana Betancor, Carlos Villalobos-Vilda, José María Olaguibel, José Manuel Rodrigo-Muñoz, María Jose Alvarez Puebla, Ebymar Arismendi, Pilar Barranco, Blanca Barroso, Irina Bobolea, Blanca Cárdaba, María Jesús Cruz, Elena Curto, Victoria Del Pozo, Javier Domínguez-Ortega, Francisco-Javier González-Barcala, Juan Alberto Luna-Porta, Carlos Martínez-Rivera, Joaquim Mullol, Xavier Muñoz, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto-Retes, Antonio Valero, Marcela Valverde-Monge, Joaquín Sastre
Archivos De Bronconeumologia, 2023 - Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis
Marcos Matabuena, Francisco Javier Salgado, Juan José Nieto-Fontarigo, María J. Álvarez-Puebla, Ebymar Arismendi, Pilar Barranco, Irina Bobolea, María L. Caballero, José Antonio Cañas, Blanca Cárdaba, María Jesus Cruz, Elena Curto, Javier Domínguez-Ortega, Juan Alberto Luna, Carlos Martínez-Rivera, Joaquim Mullol, Xavier Muñoz, Javier Rodriguez-Garcia, José María Olaguibel, César Picado, Vicente Plaza, Santiago Quirce, Manuel J. Rial, Christian Romero-Mesones, Beatriz Sastre, Lorena Soto-Retes, Antonio Valero, Marcela Valverde-Monge, Victoria Del Pozo, Joaquín Sastre, Francisco Javier González-Barcala
Archivos De Bronconeumologia, 2023 - Clinical Impact of Electronic Monitoring Devices of Inhalers in Adults with Asthma or COPD: A Systematic Review and Meta-Analysis
Noe Garin, Borja Zarate-Tamames, Laura Gras-Martin, Raimon Milà, Astrid Crespo-Lessmann, Elena Curto, Marta Hernandez, Conxita Mestres, Vicente Plaza
Pharmaceuticals, 2023 - Corrigendum to: Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia (J Asthma Allergy. 2023, 16, 95–103.)
Astrid Crespo-Lessmann, Elena Curto, Eder Freddy Mateus Medina, Esther Palones, Alicia Belda Soler, Soraya Sánchez Maza, Lorena Soto-Retes, Vicente Plaza
Journal of Asthma and Allergy, 2023 - Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia
Esther Palones, Elena Curto, Anna Pelegrí, Marina Arilla, Ingrid Solanes, Astrid Crespo-Lessmann
Archivos De Bronconeumologia, 2023 - Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
Astrid Crespo-Lessmann, Elena Curto, Eder Freddy Mateus Medina, Esther Palones, Alicia Belda Soler, Soraya Sánchez Maza, Lorena Soto-Retes, Vicente Plaza
Journal of Asthma and Allergy, 2023 - Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti–IL-5 Biologics: A Real-Life Study
B Barroso, M Valverde-Monge, I Alobid, JM Olaguibel, MJ Rial, S Quirce, E Arismendi, P Barranco, D Betancor, I Bobolea, B Cárdaba, MJ Cruz Carmona, E Curto, J Domínguez-Ortega, FJ González-Barcala, C Martínez-Rivera, I Mahíllo-Fernández, X Muñoz, C Picado, V Plaza, JM Rodrigo Muñoz, L Soto-Retes, A Valero, V del Pozo, J Mullol, J Sastre
Journal of Investigational Allergology and Clinical Immunology, 2023 - Reply to “Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies”
B Barroso, M Valverde-Monge, I Alobid, JM Olaguibel, MJ Rial, S Quirce, E Arismendi, P Barranco, D Betancor, I Bobolea, B Cárdaba, MJ Cruz Carmona, E Curto, J Domínguez-Ortega, FJ González-Barcala, C Martínez-Rivera, I Mahíllo-Fernández, X Muñoz, C Picado, V Plaza, JM Rodrigo Muñoz, L Soto-Retes, A Valero, V del Pozo, J Mullol, J Sastre
Journal of Investigational Allergology and Clinical Immunology, 2023 - Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
J Domínguez-Ortega, JA Luna-Porta, JM Olaguibel, P Barranco, E Arismendi, B Barroso, D Betancor, I Bobolea, ML Caballero, B Cárdaba, MJ Cruz, E Curto, FJ González-Barcala, I Losantos-García, C Martínez-Rivera, P Mendez-Brea, J Mullol, X Muñoz, C Picado, V Plaza, V del Pozo, MJ Rial, J Sastre, L Soto, A Valero, M Valverde-Monge, S Quirce
Journal of Investigational Allergology and Clinical Immunology, 2023 - Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma
C Betancor, JM Olaguibel, JM Rodrigo-Muñoz, MJ Alvarez Puebla, E Arismendi, P Barranco, B Barroso, I Bobolea, B Cárdaba, MJ Cruz, E Curto, V Del Pozo, J Domínguez-Ortega, FJ González-Barcala, JA Luna-Porta, C Martínez-Rivera, J Mullol, X Muñoz, C Picado, V Plaza, S Quirce, MJ Rial, L Soto-Retes, A Valero, M Valverde-Monge, J Sastre
Journal of Investigational Allergology and Clinical Immunology, 2023 - Identification of Two Eosinophil Subsets in Induced Sputum from Patients with Allergic Asthma According to CD15 and CD66b Expression
Elena Curto, Éder F. Mateus-Medina, Astrid Crespo-Lessmann, Rubén Osuna-Gómez, Cristina Ujaldón-Miró, Alba García-Moral, Paula Galván-Blasco, Lorena Soto-Retes, David Ramos-Barbón, Vicente Plaza
International Journal of Environmental Research and Public Health, 2022 - How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?
Diana Betancor, José María Olaguibel, José Manuel Rodrigo‐Muñoz, Ebymar Arismendi, Pilar Barranco, Blanca Barroso, Irina Bobolea, Blanca Cárdaba, María Jesús Cruz, Elena Curto, Victoria Del Pozo, Francisco‐Javier González‐Barcala, Carlos Martínez‐Rivera, Joaquim Mullol, Xavier Muñoz, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto, Antonio Valero, Marcela Valverde‐Monge, Joaquin Sastre
Clinical and Translational Allergy, 2022 - Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
Alvar Agustí, Gaston De Stefano, Alberto Levi, Xavier Muñoz, Christian Romero-Mesones, Oriol Sibila, Alejandra Lopez-Giraldo, Vicente Plaza Moral, Elena Curto, Andrés L. Echazarreta, Silvana E. Márquez, Sergi Pascual-Guàrdia, Salud Santos, Alicia Marin, Luis Valdés, Fernando Saldarini, Clara Salgado, Georgina Casanovas, Sara Varea, José Ríos, Rosa Faner
European Respiratory Journal, 2022 - Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort
Leyre Baptista-Serna, José Manuel Rodrigo-Muñoz, Pablo Mínguez, Marcela Valverde-Monge, Ebymar Arismendi, Pilar Barranco, Blanca Barroso, Irina Bobolea, José Antonio Cañas, Blanca Cárdaba, María Jesús Cruz, Elena Curto, Javier Domínguez-Ortega, Raquel García-Latorre, Francisco J. González-Barcala, Carlos Martínez-Rivera, Joaquim Mullol, Xavier Muñoz, José María Olaguibel, César Picado, Vicente Plaza, Santiago Quirce, Manuel J. Rial, Beatriz Sastre, Lorena Soto, Antonio Valero, Victoria del Pozo, Joaquín Sastre
Journal of Allergy and Clinical Immunology in Practice, 2022 - How to Approach Non Eosinophilic Asthma? Results of a Survey Conducted by the SEPAR Emerging Asthma Group
Elena Curto Sánchez, Íñigo Ojanguren Arranz, Marina Blanco-Aparicio, Astrid Crespo-Lessmann, Vicente Plaza Moral, Carolina Cisneros Serrano, José Serrano Pariente
Open Respiratory Archives, 2022 - Association of the CFTR gene with asthma and airway mucus hypersecretion
Astrid Crespo-Lessmann, Sara Bernal, Elisabeth del Río, Ester Rojas, Carlos Martínez-Rivera, Nuria Marina, Abel Pallarés-Sanmartín, Silvia Pascual, Juan Luis García-Rivero, Alicia Padilla-Galo, Elena Curto, Carolina Cisneros, José Serrano, Montserrat Baiget, Vicente Plaza, and
Plos One, 2021 - Therapeutic Adherence of COPD Patients According to the Involvement Levels in Health Education in their Centers
Vicente Plaza, Carmen Fernández, Elena Curto, M. Bel,n Alonso-Ortiz, Miren Itxaso Orue, José María Vega, Borja G. Cosío, Jordi Giner
Archivos De Bronconeumologia, 2021 - Therapeutic adherence of COPD patients according to levels of involvement in health education in their sites
Vicente Plaza, Carmen Fernández, Elena Curto, M. Belén Alonso-Ortiz, Miren Itxaso Orue, José María Vega, Borja G. Cosío, Jordi Giner
Archivos De Bronconeumologia, 2021 - Reply to “Managing T2-high severe asthma in HIV-infected patients”
Elena Curto, Alfons Torrego, Noe Garin, Astrid Crespo-Lessmann, Vicente Plaza
Journal of Allergy and Clinical Immunology in Practice, 2021 - Assessing adherence by combining the test of adherence to inhalers with pharmacy refill records
V Plaza, , J Giner, E Curto, MB Alonso-Ortiz, MI Orue, JM Vega, BG Cosío
Journal of Investigational Allergology and Clinical Immunology, 2021 - Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
Manuel Jorge Rial, Marcela Valverde, Victoria del Pozo, Francisco Javier González-Barcala, Carlos Martínez-Rivera, Xavier Muñoz, José María Olaguibel, Vicente Plaza, Elena Curto, Santiago Quirce, Pilar Barranco, Javier Domínguez-Ortega, Joaquin Mullol, César Picado, Antonio Valero, Irina Bobolea, Ebymar Arismendi, Paula Ribó, Joaquín Sastre
Journal of Allergy and Clinical Immunology in Practice, 2021 - HIV-infected patient with severe asthma treated with mepolizumab: Case report
Elena Curto, Alfons Torrego, Noe Garin, Astrid Crespo-Lessmann, Vicente Plaza
Journal of Allergy and Clinical Immunology in Practice, 2020 - Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD
Vicente Plaza, Jordi Giner, Elena Curto, M. Belén Alonso-Ortiz, Miren Itxaso Orue, José María Vega, Borja G. Cosío, Virginia Bellido Linares, Roberto Bernabeu Mora, Eva Cabrera Cesar, Ariel Callero Viera, Rafael Castillo, Julio Delgado Romero, Ma José Espinosa de los Monteros-Garde, José María Fernández Rodríguez-Lacín, José Carlos García Robaina, Aníbal Manuel Hernández Gil, José Miguel Hernández Rey, Guacimara Hernández Santana, Cristina López Ruiz, Enrique Mascaros Balaguer, Francisco Javier Mazo Echaniz, Núria Moreno Pérez, Antonio Parra Arrondo, José Portillo Sánchez, José Ramón Rodríguez Encinar, Elena Rodríguez Plata, Berta Román Bernal, Anna Sala Cunill, Fernando J. Sánchez Lora, Juan Miguel Sánchez Nieto, Joan Serra Batlles, José Joaquín Torres Relucio, Agustín Valido Morales, Rubén Luciano Vázquez Alarcón, José Luis Velasco Garrido
Journal of Allergy and Clinical Immunology in Practice, 2020 - Total and specific immunoglobulin e in induced sputum in allergic and non-allergic asthma
Astrid Crespo-Lessmann, Elena Curto, Eder Mateus, Lorena Soto, Alba García-Moral, Montserrat Torrejón, Alicia Belda, Jordi Giner, David Ramos-Barbón, Vicente Plaza
Plos One, 2020 - Pulmonary eosinophilia associated to treatment with natalizumab
MMarisol Dominguez-Alvarez, Elena Curto, Elvira Munteis-Olivas, Eva Balcells
Annals of Thoracic Medicine, 2016
